Cargando…
21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013
The purpose of this study was to determine if receipt of chemotherapy was associated with utilization of the 21-gene recurrence score assay (RS assay) or with recurrence score (RS) in eligible patients. Using the National Cancer Data Base (NCDB), we identified female patients eligible for RS assay b...
Autores principales: | Parsons, Benjamin M., Landercasper, Jeffrey, Smith, Angela L., Go, Ronald S., Borgert, Andrew J., Dietrich, Leah L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012154/ https://www.ncbi.nlm.nih.gov/pubmed/27507245 http://dx.doi.org/10.1007/s10549-016-3926-5 |
Ejemplares similares
-
Adverse drug reactions to anticoagulants in Spain: analysis of the Spanish National Hospital Discharge Data (2010–2013)
por: Carrasco-Garrido, P, et al.
Publicado: (2017) -
Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study
por: de Camargo Cancela, M, et al.
Publicado: (2013) -
A Population-Based Study of Care at the End of Life Among People With HIV in Ontario From 2010 to 2013
por: Kendall, Claire E., et al.
Publicado: (2017) -
Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors
por: Odai-Afotey, Ashley, et al.
Publicado: (2023) -
Fewer Reoperations After Lumpectomy for Breast Cancer with Neoadjuvant Rather than Adjuvant Chemotherapy: A Report from the National Cancer Database
por: Landercasper, Jeffrey, et al.
Publicado: (2017)